News Daily News Female-Specific Factors Don’t Enhance Common Risk Calculators Caitlin E. Cox December 10, 2024
News Daily News Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple L.A. McKeown December 09, 2024
News Daily News Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results Michael O'Riordan December 04, 2024
News Daily News Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis Todd Neale November 28, 2024
News Daily News ZENITH: Novel Biologic Reduces Morbidity and Mortality in PAH L.A. McKeown November 26, 2024
News Conference News AHA 2024 Indian Patients Do Well on Dual-Combination Pills for Hypertension: TOPSPIN Caitlin E. Cox November 22, 2024
News Conference News AHA 2024 Talking Sex: CVD Patients Want to Hear More From Clinicians Caitlin E. Cox November 20, 2024
News Conference News AHA 2024 ARNI Lessens Anthracycline Cardiotoxicity in High-Risk Patients: SARAH Caitlin E. Cox November 18, 2024
News Conference News AHA 2024 Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F Michael O'Riordan November 16, 2024
News Conference News AHA 2024 Intensive BP Lowering in Diabetes Reduces CV Events: BPROAD Yael L. Maxwell November 16, 2024
News Daily News Hypertensive Disorders of Pregnancy Lead to Earlier, More Severe CAD Caitlin E. Cox November 12, 2024
News Conference News VIVA 2024 DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years L.A. McKeown November 11, 2024
News Conference News VIVA 2024 Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II L.A. McKeown November 06, 2024
News Daily News Machismo in Youth Linked to Fewer CVD Diagnoses, Less Treatment in Adulthood Caitlin E. Cox November 06, 2024
News Conference News VIVA 2024 Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK L.A. McKeown November 05, 2024
Presentation TCT 2024 Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN Presenter: Raymond Townsend October 29, 2024
Presentation TCT 2024 Debate Con: RDN Will Ultimately Be a Niche Therapy Presenter: Andrew Sharp October 29, 2024
Presentation TCT 2024 Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space! Presenter: Eric Secemsky October 29, 2024
Presentation TCT 2024 Debate Pro: Predictors of Efficacy are Not Needed for Most Patients Presenter: Michael Weber October 29, 2024